Irish Journal of Medical Science

, Volume 163, Issue 1, pp 65–67 | Cite as

An outbreak of parvovirus b19 infection; a study of clinical manifestations and the incidence of fetal loss

  • J. R. Kerr
  • H. J. O’Neill
  • P. V. Coyle
  • W. Thompson
Article

Summary

Eighty-five cases of B19 infection were diagnosed in Northern Ireland from 1984 to 1989; 65 of these occurred during 1989, the outbreak year. Of the total 85 cases, 15 had a rash, 21 had arthralgia, 47 had a rash and arthralgia, and 2 had aplastic crisis. The age range was 4-63 years with a mean of 26.9 years. Thirty cases (35%) were referred to hospital; 25 of these had arthralgia and 2 had aplastic crisis.

Two thousand four hundred pregnant women at 12 weeks gestation in 1989 were screened for anti-B19 IgM; 8 were positive. Of these 8 patients, 7 progressed to delivery of a normal fetus and one had an intra-uterine death at 26 weeks gestation; no congenital abnormalities were noted in any fetus. The incidence of fetal involvement in maternal B19 infection in this study was therefore 12.5%.

Keywords

Public Health Laboratory Northern Ireland Intrauterine Death Aplastic Crisis Erythema Infectiosum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cossart, Y. E., Field, A. M., Cant, B., Widdow, D. Parvovirus- like particles in human sera. Lancet 1975; 1: 72–73.PubMedCrossRefGoogle Scholar
  2. 2.
    Anderson, M. J., Jones, S. E., Fisher-Hock, S. P. et al. Human parvovirus, the cause of Erythema Infectiosum (Fifth Disease). Lancet 1983; 1: 1378.PubMedCrossRefGoogle Scholar
  3. 3.
    Pattison, J. R., Jones, S. E., Hodgson, J. et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1981; 1: 664–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Anand, A., Gray, E. S., Brown, T., Clewley, J. P., Cohen, B.J. Human parvovirus infection in pregnancy and hydrops foetalis. N. Engl. J. Med. 1987; 316: 183.PubMedGoogle Scholar
  5. 5.
    Kurtzman, G., Frickhofen, N., Kimball, J., Jenkins, D. W., Neinhuis, A. W., Young, N. S. Pure red cell aplasia of 10 years duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med. 1989; 321(8): 519–23.PubMedGoogle Scholar
  6. 6.
    Cohen, B. J., Mortimer, P. P., Pereira, M. S. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J. Hyg. 1983; 91: 113–30.CrossRefGoogle Scholar
  7. 7.
    Anderson, M. J. Human Parvoviruses. In Zuckerman, A. J., Banatvala, J. E., Pattison, J. R. (eds). Principles and practice of clinical virology. Wiley 2nd edition 1990; pp. 561-71.Google Scholar
  8. 8.
    O’Neill, H. J., Coyle, P. V. Two anti-parvovirus B19 IgM capture assays incorporating a mouse monoclonal antibody specific for B19 viral capsid proteins VP1 & VP2. Arch Virol. 1992; 123: 125–34.PubMedCrossRefGoogle Scholar
  9. 9.
    Mortimer, P. P., Luban, N. L. C., Kelleher, J. F., Cohen, B. J. Transmission of serum parvovirus-like virus by clotting factor concentrates. Lancet 1983; 2: 482–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Knott, P. D., Welply, G. A. C., Anderson, M. J. Serologically proved intrauterine infection with parvovirus. Br. Med. J. 1984; 289: 1660.CrossRefGoogle Scholar
  11. 11.
    Brown, T., Anand, A., Ritchie, L. D., Clewley, J. P., Reid, T. M. S. Intrauterine Parvovirus infection associated with hydrops fetalis (letter). Lancet 1984; 2: 1033–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Miller, M. E., Stiehm, E. R. Immunology and resistance to infecion. In: Remington, J. S., Klein, J. O. eds. Infectious diseases of the fetus and newborn infant. 2nd ed. Philadelphia: W. B. Saunders 1983.Google Scholar
  13. 13.
    Anderson, L. J. Human Parvovirus B19. Paediatric Annals 1990; 19(9): 509–13.Google Scholar
  14. 14.
    Anderson, M. J., Khousam, M. N., Maxwell, D. J., Gould, S. J., Happerfield, L. C., Smith, W. J. Human Parvovirus B19 and hydrops fetalis. Lancet 1988; 1: 535.PubMedCrossRefGoogle Scholar
  15. 15.
    Rodis, J. F., Quinn, D. L., Gary, G. W., et al. Management and outcomes of pregnancies complicated by Human Parvovirus B19 infection: a prospective study. Am. J. Obstet. Gynecol. 1990; 163: 168–71.Google Scholar
  16. 16.
    Mortimer, P. P., Cohen, B. J., Buckley, M. M. etal. Human Parvovirus and the foetus. Lancet 1985; 2: 1012.PubMedCrossRefGoogle Scholar
  17. 17.
    Laemmli. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Woernle, C. H., Anderson, L. J., Tattersall, P., Davidson, J. M. Human Parvovirus B19 infection during pregnancy. J. Infect. Dis. 1987; 156: 17–20.PubMedGoogle Scholar
  19. 19.
    Schwarz, T. F., Roggendorf, M., Hottentrager, B. et al. Human Parvovirus B19 infection in pregnancy. Lancet 1988; 2: 566–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Public Health Laboratory Service Working Party on Fifth’s Disease. Prospective study of Human Parvovirus (B19) infection in pregnancy. Br. Med. J 1990; 300: 1166–70.Google Scholar

Copyright information

© Springer 1994

Authors and Affiliations

  • J. R. Kerr
    • 1
  • H. J. O’Neill
    • 1
  • P. V. Coyle
    • 1
  • W. Thompson
    • 1
  1. 1.Royal Victoria HospitalBelfast

Personalised recommendations